The Scientific Advisory Board is responsible for defining the topics of each conference, assuring they are timely and relevant so as to stimulate dissemination and discussion of current advances in cheminformatics research. They also review all scientific abstracts submitted for the plenary and poster sessions.

The Board is comprised of the following scientists:

• Peter Ertl, Novartis
• Kimito Funatsu, Department of Chemical System Engineering of the University of Tokyo
• Val Gillet, University of Sheffield
• Rajarshi Guha, NIH Chemical Genomics Center
• Michael Lajiness, Eli Lilly and Company
• Jordi Mestres, Hospital del Mar Research Institute(IMIM)
• Matthias Rarey, Zentrum für Bioinformatik of the Universität Hamburg
• Keith T Taylor, Accelrys, Inc.
• Lothar Terfloth, Molecular Networks
• Markus Wagener, MSD
• W. Patrick Walters, Vertex Pharmaceuticals, Inc.